UBS Group’s Biodexa Pharmaceuticals BDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.72K Sell
199
-1,684
-89% -$14.6K ﹤0.01% 8250
2025
Q1
$24.9K Buy
1,883
+1,178
+167% +$15.6K ﹤0.01% 6778
2024
Q4
$28.5K Sell
705
-317
-31% -$12.8K ﹤0.01% 6414
2024
Q3
$72K Buy
1,022
+982
+2,455% +$69.2K ﹤0.01% 5388
2024
Q2
$8.96K Buy
40
+30
+300% +$6.72K ﹤0.01% 6612
2024
Q1
$3.95K Buy
10
+8
+400% +$3.16K ﹤0.01% 6507
2023
Q4
$1.61K Buy
+2
New +$1.61K ﹤0.01% 7049
2023
Q3
Sell
-7
Closed -$9.81K 7409
2023
Q2
$9.81K Buy
+7
New +$9.81K ﹤0.01% 6085
2023
Q1
Hold
0
-$123 8478
2022
Q4
Hold
0
-$6K 9173
2022
Q3
Hold
0
-$2K 7896
2022
Q2
Hold
0
-$4K 8463
2022
Q1
Hold
0
8214
2021
Q3
Hold
0
-$16K 8353
2021
Q2
Hold
0
-$52K 6466
2021
Q1
Hold
0
-$2K 5487
2020
Q4
Hold
0
7048
2020
Q3
Hold
0
-$42K 7073
2020
Q2
Hold
0
-$5K 5169
2020
Q1
Hold
0
-$2K 6352
2019
Q4
Hold
0
6736
2019
Q3
Hold
0
-$3K 6993
2019
Q2
Hold
0
6644
2019
Q1
Hold
0
-$4K 6859
2018
Q4
Hold
0
-$6K 6681
2018
Q3
Hold
0
-$4K 6470
2018
Q2
Hold
0
6604
2018
Q1
Hold
0
-$1K 6881
2017
Q4
Hold
0
-$4K 6711
2017
Q3
Hold
0
6376
2017
Q2
Hold
0
-$6K 6684
2017
Q1
Hold
0
-$4K 5953
2016
Q4
Hold
0
-$5K 6332
2016
Q3
Hold
0
6181
2016
Q1
Hold
0
-$12K 6693
2015
Q4
Hold
0
5893